Company: AEMD
Filing Date: 2025-04-08
Form Type: PRE 14A
Source: 0001683168-25-002332
Chunk: 16

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-08
Form: PRE 14A
Chunk 16
---
 Audit Committee is to consider the material facts of the transaction, including whether the transaction is on terms
no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent
of the related person’s interest in the transaction.

| 8 |

<div align='center'>PROPOSAL No. 1 –APPROVAL OF A REVERSE STOCK SPLIT OF OUR COMMON STOCK AT A RATIO IN THE RANGE OF 1-FOR-5 TO 1-FOR-12, WITH SUCH RATIO TO BE DETERMINED IN THE DISCRETION OF OUR BOARD OF DIRECTORS AND WITH SUCH REVERSE STOCK SPLIT TO BE EFFECTED AT SUCH TIME AND DATE AS DETERMINED BY OUR BOARD OF DIRECTORS IN ITS SOLE DISCRETION (BUT IN NO EVENT LATER THAN May 13, 2026)</div>

Background

Our Board of Directors has unanimously approved a
reverse stock split of all issued and outstanding shares of our common stock, at a ratio ranging from 1-for-5 to 1-for-12, inclusive,
or the Reverse Stock Split, pursuant to Nevada Revised Statutes, or NRS, 78.2055.

Effecting the Reverse Stock Split would reduce the
number of outstanding shares of our common stock. The determination to effect a Reverse Stock Split, including the ratio and the effective
date and time of any such Reverse Stock Split, will be determined by our Board of Directors within a reasonable time following the Special
Meeting. Our Board of Directors has recommended that the proposed Reverse Stock Split be presented to, and approved by, our stockholders.

Pursuant to Proposal 1, our stockholders are being
asked to approve a Reverse Stock Split of our common stock at a ratio in the range of 1-for-5 to 1-for-12, and to grant authorization
to our Board of Directors to determine, in its discretion, whether to implement a Reverse Stock Split, including its specific timing and
ratio within the specified range.

Should we receive the required stockholder approval
for Proposal 1, our Board of Directors will have the sole authority to determine, and without the need for any further action on
the part of our stockholders, whether to effect the Reverse Stock Split and the number of whole shares of our common stock, between and
including 5 and 12, that will be combined into one share of our common stock.

By approving Proposal 1, our stockholders will: